Omicron (B.1.1.529 variant of SARS-CoV-2); an emerging threat: Current global scenario

Affiliations

¹ Department of Chemistry, Government College of Engineering, Keonjhar, Odisha, India.
² Department of Chemistry, School of Applied Sciences, Centurion University of Technology and Management, Odisha, India.
³ Department of Microbiology, Prathima Institute of Medical Sciences, Karimnagar, Telangana, India.
⁴ Department of Chemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.
⁵ Department of Veterinary Microbiology and Immunology, College of Veterinary Sciences, Uttar Pradesh Pandit Deen Dayal Upadhyaya Pashu Chikitsa Vigyan Vishwavidyalaya Evam Go Anusandhan Sansthan (DUVASU), Mathura, India.
⁶ Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India.

Ranjan K Mohapatra et al. J Med Virol. 2022 May.

. 2022 May;94(5):1780-1783.

doi: 10.1002/jmv.27561. Epub 2022 Jan 5.

¹ Department of Chemistry, Government College of Engineering, Keonjhar, Odisha, India.
² Department of Chemistry, School of Applied Sciences, Centurion University of Technology and Management, Odisha, India.
³ Department of Microbiology, Prathima Institute of Medical Sciences, Karimnagar, Telangana, India.
⁴ Department of Chemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.
⁵ Department of Veterinary Microbiology and Immunology, College of Veterinary Sciences, Uttar Pradesh Pandit Deen Dayal Upadhyaya Pashu Chikitsa Vigyan Vishwavidyalaya Evam Go Anusandhan Sansthan (DUVASU), Mathura, India.
⁶ Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India.

No abstract available

Conflict of interest statement

The authors declare that there are no conflict of interests.

1. Dhama K, Khan S, Tiwari R, et al. Coronavirus disease 2019‐COVID‐19. Clin Microbiol Rev. 2020;33(4):e00028‐20. 10.1128/CMR.00028-20 - DOI - PMC - PubMed
1. Mohapatra RK, Perekhoda L, Azam M, et al. Computational investigations of three maindrugs and their comparison with synthesized compounds as potentinhibitors of SARS‐CoV‐2 main protease (Mpro): DFT, QSAR, moleculardocking, and in silico toxicity analysis. J King Saud Univ Sci. 2021;33:101315. - PMC - PubMed
1. Mohapatra RK, Pintilie L, Kandi V, et al. The recent challenges of highly contagious COVID‐19; causing respiratory infections: symptoms, diagnosis, transmission, possible vaccines, animal models and immunotherapy. Chem Biol Drug Des. 2020;96:1187‐1208. - PMC - PubMed
1. WHO . WHO Coronavirus (COVID‐19) Dashboard. WHO COVID‐19 Dashboard—Up to date data on pandemic; 2021. Accessed December 18, 2021. https://covid19.who.int/?gclid=CjwKCAiA65iBBhB-EiwAW253W0GZ9U6TBkdh4YsVu...
1. CDC . SARS‐CoV‐2 Variant Classifications and Definitions. Accessed December 1, 2021. https://www.cdc.gov/